Long-Term Vascular Function in CTO Recanalization: A Randomized Clinical Trial of Ticagrelor vs. Clopidogrel.

MLA

Rodriguez-Arias, Juan J., et al. “Long-Term Vascular Function in CTO Recanalization: A Randomized Clinical Trial of Ticagrelor vs. Clopidogrel.” Cardiovascular Revascularization Medicine : Including Molecular Interventions, vol. 37, Apr. 2022, pp. 61–67. EBSCOhost, https://doi.org/10.1016/j.carrev.2021.06.129.

APA

Rodriguez-Arias, J. J., Gomez-Lara, J., Caballero-Borrego, J., Ortega-Paz, L., Arévalos, V., Teruel, L., Gil-Jimenez, T., Oyarzabal, L., Romaguera, R., Moreno-Terribas, G., Gomez-Hospital, J.-A., Sabate, M., & Brugaletta, S. (2022). Long-Term Vascular Function in CTO Recanalization: A Randomized Clinical Trial of Ticagrelor vs. Clopidogrel. Cardiovascular Revascularization Medicine : Including Molecular Interventions, 37, 61–67. https://doi.org/10.1016/j.carrev.2021.06.129

Chicago

Rodriguez-Arias, Juan J, Josep Gomez-Lara, Juan Caballero-Borrego, Luis Ortega-Paz, Victor Arévalos, Luis Teruel, Teresa Gil-Jimenez, et al. 2022. “Long-Term Vascular Function in CTO Recanalization: A Randomized Clinical Trial of Ticagrelor vs. Clopidogrel.” Cardiovascular Revascularization Medicine : Including Molecular Interventions 37 (April): 61–67. doi:10.1016/j.carrev.2021.06.129.